61 Publications (Page 2 of 3)
2014
Pharmacokinetics of levetiracetam in healthy hispaniolan amazon parrots (Amazona ventralis) after oral administration of a single dose
Schnellbacher, R.Beaufrère, H.Arnold, R.D.Tully, T.N.Mayer, J. and Divers, S.J.
Journal of Avian Medicine and Surgery, vol. 28, pp. 193-200. | Journal Article
 
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
Quach, N DMock, J NScholpa, N EEggert, M WPayré, CLambeau, GArnold, R D and Cummings, B S
Molecular pharmaceutics, vol. 11, (no. 10), pp. 3443-3451, October 6, 2014. | Journal Article
 
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.
Quach, Nhat DArnold, Robert D and Cummings, Brian S
Biochemical pharmacology, vol. 90, (no. 4), pp. 338-48, 2014/Aug/15. | Journal Article
 
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
De, ChandravLiu, DongmeiZheng, BoSingh, Uma SChavre, SatishWhite, CatherineArnold, Robert DHagen, Fred KChu, Chung K and Moffat, Jennifer F
Antiviral research, vol. 110, pp. 10-19, October 2014. | Journal Article
2013
Effect of age on the pharmacokinetics of a single daily dose of gentamicin sulfate in healthy foals.
Burton, A JGiguère, SWarner, LAlhamhoom, Y and Arnold, Robert D
Equine veterinary journal, vol. 45, (no. 4), pp. 507-11, 2013/Jul. | Journal Article
 
Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
Mock, J NCostyn, L JWilding, S LArnold, Robert D and Cummings, Brian S
Integrative biology : quantitative biosciences from nano to macro, vol. 5, (no. 1), pp. 172-82, 2013/Jan. | Journal Article
 
Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier.
Jung, JiyoungArnold, Robert D and Wicker, Louise
Colloids and surfaces. B, Biointerfaces, vol. 104, pp. 116-121, April 1, 2013. | Journal Article
2012
Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models.
Zhao, QunWang, LuningCheng, RuiMao, LeidongArnold, Robert DHowerth, Elizabeth WChen, Zhuo G and Platt, Simon
Theranostics, vol. 2, pp. 113-21, 2012. | Journal Article
 
Mechanisms of Tumor Vascular Priming by a Nanoparticulate Doxorubicin Formulation
Roy Chaudhuri, TistaArnold, Robert DYang, JunTurowski, Steven GQu, YangSpernyak, Joseph AMazurchuk, Richard VMager, Donald E and Straubinger, Robert M
Pharmaceutical Research, vol. 29, (no. 12), pp. 3312-24, Dec 2012. | Journal Article
 
Pharmacokinetic assessment of ketanserin in the horse.
Aljuffali, I ABrainard, B MMoore, J NKwon, SAllen, DRobertson, T P and Arnold, R D
Journal of veterinary pharmacology and therapeutics, vol. 35, (no. 5), pp. 472-477, October 2012. | Journal Article
2011
Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer.
Aljuffali, Ibrahim AMock, Jason NCostyn, Leah JNguyen, HaNagy, TamasCummings, Brian S and Arnold, Robert D
Cancer biology & therapy, vol. 12, (no. 5), pp. 407-20, 2011/Sep/1. | Journal Article
 
Secretory phospholipase A₂ responsive liposomes.
Zhu, GuodongMock, Jason NAljuffali, Ibrahim ACummings, Brian S and Arnold, Robert D
Journal of pharmaceutical sciences, vol. 100, (no. 8), pp. 3146-59, 2011/Aug. | Journal Article
 
Synthesis of lipids for development of multifunctional lipid-based drug-carriers.
Zhu, GuodongAlhamhoom, YahyaCummings, Brian S and Arnold, Robert D
Bioorganic & medicinal chemistry letters, vol. 21, (no. 21), pp. 6370-5, 2011/Nov/1. | Journal Article
 
The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer.
Kang, Jeong YCostyn, Leah JNagy, TamasCowan, Elizabeth AOldham, Charlie DMay, Sheldon W and Arnold, Robert D
Archives of biochemistry and biophysics, vol. 515, (no. 1-2), pp. 112-9, 2011/Nov. | Journal Article
2010
Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
Zhang, ShuzhongSagawa, KazukoArnold, Robert DTseng, ElaineWang, Xiaodong and Morris, Marilyn E
Journal of pharmaceutical sciences, vol. 99, (no. 1), pp. 430-41, 2010/Jan. | Journal Article
2009
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients
Bulitta, Jürgen BZhao, PingArnold, Robert DKessler, Dean RDaifuku, RichardPratt, JamesLuciano, GabrielHanauske, Axel-RGelderblom, HansAwada, Ahmad and Jusko, William
Cancer chemotherapy and pharmacology., vol. 63, (no. 6), pp. 1049-1063, 2009. | Journal Article
 
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients
Bulitta, Juergen BZhao, PingArnold, Robert DKessler, Dean RDaifuku, RichardPratt, JamesLuciano, GabrielHanauske, Axel-RGelderblom, HansAwada, Ahmad and Jusko, William
Cancer Chemotherapy and Pharmacology, vol. 63, (no. 6), pp. 1035-1048, 2009. | Journal Article
2007
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O’Connor, R.O’Leary, M.Ballot, J.Collins, C.D.Kinsella, P.Mager, D.E.Arnold, R.D.O’Driscoll, L.Larkin, A.Kennedy, S.Fennelly, D.Clynes, M. and Crown, J.
Cancer Chemotherapy and Pharmacology, vol. 59, pp. 79-87. | Journal Article
 
Biotechnology-Derived Drug Product Development
Carl, S.M.Lindley, D.J.Knipp, G.T.Morris, K.R.Oliver, E.Becker, G.W. and Arnold, R.D.
2007
2006
A Phase 1 clinical and pharmacokinetic study of the Multidrug Resistance Protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O'Conner, RO'Leary, M.O., Ballot, R., Collins, C., Kinsella, P., Mager, D.M., Arnold, R.D., O'Driscoll, L.O., Larkin, A.M., Kennedy, S., Fennelly, D., Clynes, M., and Crown, J. and Arnold, Robert D
Cancer Chemotherapy and Pharmacology, 2006. | Journal Article
2005
Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution
Arnold, Robert DMager, D.E.Slack, J.E. and Straubinger, R.M
Clinical Cancer Research, 2005. | Journal Article
 
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Arnold, Robert DMager, Donald ESlack, Jeanine E and Straubinger, Robert M
Clinical Cancer Research, vol. 11, (no. 24), pp. 8856-8865, 2005. | Journal Article
 
Tumor antivascular effects of sterically-stabilized doxorubicin-containing liposomes
Arnold, R.D.,Mager, D.E., Spernyak, J.A., Mazurchuk, R.V., Straubinger, R. and Arnold, Robert D
AACR National Meeting, Anaheim, CA.. 2005. | Conference Proceeding
2004
Altered plasma pharmacokinetics, tumor/tissue biodistribution, and barrier properties of the tumor microvasculature in rats following repetitive dosing of doxorubicin liposomes
Arnold, R.D.,Slack, J.E., Mager, D.E., R., Spernyak, J., Mazurchuk, R., Straubinger, R. and Arnold, Robert D
Advances in Liposomes: New Technologies and New Therapies, Chicago, IL. 2004. | Conference Proceeding
 
Antivascular and antitumor activities of liposome-associated drugs
Straubinger RMArnold, Robert DZhou RMazurchuk R and Slack JE
Anticancer Research, vol. 24, (no. 2A), pp. 397-404, Mar-Apr 2004. | Journal Article